These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20061736)

  • 1. Updosing of antihistamines to improve control of chronic urticaria.
    Godse KV
    Indian J Dermatol Venereol Leprol; 2010; 76(1):61-2. PubMed ID: 20061736
    [No Abstract]   [Full Text] [Related]  

  • 2. Increasing the dose of cetirizine may lead to better control of chronic idiopathic urticaria: an open study of 21 patients.
    Kameyoshi Y; Tanaka T; Mihara S; Takahagi S; Niimi N; Hide M
    Br J Dermatol; 2007 Oct; 157(4):803-4. PubMed ID: 17627798
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonsedating antihistamines in the treatment of severe chronic idiopathic urticaria: are they used optimally?
    Cheung ST; Tucker W
    Br J Dermatol; 2006 May; 154(5):1012-3. PubMed ID: 16634919
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose antihistamines for chronic spontaneous urticaria in adults.
    Drug Ther Bull; 2018 Apr; 56(4):45-48. PubMed ID: 29650762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic urticaria: do urticaria nonexperts implement treatment guidelines? A survey of adherence to published guidelines by nonexperts.
    Ferrer M; Jáuregui I; Bartra J; Dávila I; del Cuvillo A; Montoro J; Mullol J; Valero A; Sastre J
    Br J Dermatol; 2009 Apr; 160(4):823-7. PubMed ID: 19120332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above-licensed doses.
    Asero R
    Clin Exp Dermatol; 2007 Jan; 32(1):34-8. PubMed ID: 17042777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg.
    Giménez-Arnau A; Izquierdo I; Maurer M
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1088-91. PubMed ID: 19453774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of reserpine as "add-on therapy" to antihistamines in patients with recalcitrant chronic idiopathic urticaria and urticarial vasculitis.
    Demitsu T; Yoneda K; Kakurai M; Sasaki K; Hiratsuka Y; Azuma R; Yamada T; Umemoto N
    J Dermatol; 2010 Sep; 37(9):827-9. PubMed ID: 20883370
    [No Abstract]   [Full Text] [Related]  

  • 9. What the first 10,000 patients with chronic urticaria have taught me: a personal journey.
    Kaplan AP
    J Allergy Clin Immunol; 2009 Mar; 123(3):713-7. PubMed ID: 19081615
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of refractory chronic urticaria with sirolimus.
    Morgan M
    Arch Dermatol; 2009 Jun; 145(6):637-9. PubMed ID: 19528416
    [No Abstract]   [Full Text] [Related]  

  • 11. [Urticaria and antihistamines].
    Tousignant J; Côté B; Barolet D
    Can Fam Physician; 1993 Jan; 39():132-40. PubMed ID: 8435550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on acute and chronic urticaria for the primary care provider.
    Najib U; Sheikh J
    Postgrad Med; 2009 Jan; 121(1):141-51. PubMed ID: 19179823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Self assessment of the effect of antihistaminics by patients with chronic recurring urticaria].
    Ziegler B; Haustein UF
    Dermatol Monatsschr; 1986; 172(3):163-7. PubMed ID: 3699212
    [No Abstract]   [Full Text] [Related]  

  • 14. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
    Nettis E; Colanardi MC; Barra L; Ferrannini A; Vacca A; Tursi A
    Br J Dermatol; 2006 Mar; 154(3):533-8. PubMed ID: 16445787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of short- and long-term cyclosporine A therapy in chronic idiopathic urticaria.
    Baskan EB; Tunali S; Turker T; Saricaoglu H
    J Dermatolog Treat; 2004 Jun; 15(3):164-8. PubMed ID: 15204149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond antihistamines: treating chronic urticaria.
    Balaraman B; Bergstrom KG
    J Drugs Dermatol; 2009 Nov; 8(11):1043-8. PubMed ID: 19894375
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined H1 and H2 antihistamine therapy in chronic urticaria.
    Monroe EW; Cohen SH; Kalbfleisch J; Schulz CI
    Arch Dermatol; 1981 Jul; 117(7):404-7. PubMed ID: 6114712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy of four antihistamines in chronic urticaria.
    Youngchaiyud U
    J Med Assoc Thai; 1988 Oct; 71(10):548-52. PubMed ID: 2907911
    [No Abstract]   [Full Text] [Related]  

  • 19. Methotrexate: a useful steroid-sparing agent in recalcitrant chronic urticaria.
    Perez A; Woods A; Grattan CE
    Br J Dermatol; 2010 Jan; 162(1):191-4. PubMed ID: 19903174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical exacerbation of chronic urticaria by H1-antihistamines and montelukast.
    Tedeschi A
    Eur Ann Allergy Clin Immunol; 2009 Dec; 41(6):187-9. PubMed ID: 20128233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.